Literature DB >> 22014214

The CB1 cannabinoid receptor C-terminus regulates receptor desensitization in autaptic hippocampal neurones.

Alex Straiker1, Jim Wager-Miller, Ken Mackie.   

Abstract

BACKGROUND AND
PURPOSE: The cannabinoid CB(1) receptor is the chief mediator of the CNS effects of cannabinoids. In cell culture model systems, CB(1) receptors both desensitize and internalize on activation. Previous work suggests that the extreme carboxy-terminus of this receptor regulates internalization via phosphorylation of residues clustered within this region. Mutational analysis of the carboxy-terminus of CB(1) receptors has demonstrated that the last six serine/threonine residues are necessary for agonist-induced internalization. However, the structural determinants of CB(1) receptor internalization are also dependent on the local cellular environment. The importance of cell context on CB(1) receptor function calls for an investigation of the functional roles of these residues in neurones. EXPERIMENTAL APPROACH: To determine the structural requirements of CB(1) internalization in neurones, we evaluated the signalling properties of carboxy-terminal mutated CB(1) receptors expressed in cultured autaptic hippocampal neurones, using electrophysiological methods. KEY
RESULTS: CB(1) receptors transfected into CB(1) knockout neurones signalled and desensitized as did wild-type neurones, allowing us to test specific CB(1) receptor mutations. Deletion of the last 13 residues yielded a CB(1) receptor that inhibited excitatory postsynaptic currents but did not desensitize. Furthermore, mutation of the final six serine and threonine residues to alanines resulted in a non-desensitizing receptor. In contrast, CB(1) receptors lacking residues 419-460, leaving the last 14 residues intact, did desensitize. CONCLUSIONS AND IMPLICATIONS: The distal thirteen residues of CB(1) receptors are crucial for their desensitization in cultured neurones. Furthermore, this desensitization is likely to follow phosphorylation of serines and threonines within this region. LINKED ARTICLES: This article is part of a themed section on Cannabinoids in Biology and Medicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue-8. To view Part I of Cannabinoids in Biology and Medicine visit http://dx.doi.org/10.1111/bph.2011.163.issue-7.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22014214      PMCID: PMC3423230          DOI: 10.1111/j.1476-5381.2011.01743.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons.

Authors:  A A Coutts; S Anavi-Goffer; R A Ross; D J MacEwan; K Mackie; R G Pertwee; A J Irving
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

Review 2.  Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins.

Authors:  Audrey Claing; Stéphane A Laporte; Marc G Caron; Robert J Lefkowitz
Journal:  Prog Neurobiol       Date:  2002-02       Impact factor: 11.685

3.  Guide to Receptors and Channels (GRAC), 5th edition.

Authors:  Stephen P H Alexander; Alistair Mathie; John A Peters
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

4.  Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals.

Authors:  T Ohno-Shosaku; T Maejima; M Kano
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

5.  Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain.

Authors:  C S Breivogel; S R Childers; S A Deadwyler; R E Hampson; L J Vogt; L J Sim-Selley
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

6.  Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice.

Authors:  C E Bass; B R Martin
Journal:  Drug Alcohol Depend       Date:  2000-08-01       Impact factor: 4.492

7.  Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture.

Authors:  Maria Kouznetsova; Brooke Kelley; Maoxing Shen; Stanley A Thayer
Journal:  Mol Pharmacol       Date:  2002-03       Impact factor: 4.436

8.  Cannabinoid CB1 receptor-dependent long-term depression in autaptic excitatory neurons.

Authors:  Ryan Kellogg; Ken Mackie; Alex Straiker
Journal:  J Neurophysiol       Date:  2009-06-03       Impact factor: 2.714

9.  Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism.

Authors:  Tanya L Daigle; Mary Lee Kwok; Ken Mackie
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

10.  Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis.

Authors:  Brady K Atwood; Jacqueline Lopez; James Wager-Miller; Ken Mackie; Alex Straiker
Journal:  BMC Genomics       Date:  2011-01-07       Impact factor: 3.969

View more
  10 in total

1.  Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice.

Authors:  Daniel J Morgan; Brian J Davis; Chris S Kearn; David Marcus; Alex J Cook; Jim Wager-Miller; Alex Straiker; Michael H Myoga; Jeffrey Karduck; Emma Leishman; Laura J Sim-Selley; Traci A Czyzyk; Heather B Bradshaw; Dana E Selley; Ken Mackie
Journal:  J Neurosci       Date:  2014-04-09       Impact factor: 6.167

2.  AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.

Authors:  C M Keenan; M A Storr; G A Thakur; J T Wood; J Wager-Miller; A Straiker; M R Eno; S P Nikas; M Bashashati; H Hu; K Mackie; A Makriyannis; K A Sharkey
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

3.  Novel insights into CB1 cannabinoid receptor signaling: a key interaction identified between the extracellular-3 loop and transmembrane helix 2.

Authors:  Jahan Marcu; Derek M Shore; Ankur Kapur; Megan Trznadel; Alexandros Makriyannis; Patricia H Reggio; Mary E Abood
Journal:  J Pharmacol Exp Ther       Date:  2013-02-20       Impact factor: 4.030

4.  Brain CB₁ receptor expression following lipopolysaccharide-induced inflammation.

Authors:  H Hu; W Ho; K Mackie; Q J Pittman; K A Sharkey
Journal:  Neuroscience       Date:  2012-10-04       Impact factor: 3.590

5.  CB₂ cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons.

Authors:  Brady K Atwood; Alex Straiker; Ken Mackie
Journal:  Neuropharmacology       Date:  2012-05-08       Impact factor: 5.250

Review 6.  Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R).

Authors:  Alexandra Fletcher-Jones; Keri L Hildick; Ashley J Evans; Yasuko Nakamura; Jeremy M Henley; Kevin A Wilkinson
Journal:  Front Mol Neurosci       Date:  2020-06-12       Impact factor: 5.639

7.  Subsynaptic Distribution, Lipid Raft Targeting and G Protein-Dependent Signalling of the Type 1 Cannabinoid Receptor in Synaptosomes from the Mouse Hippocampus and Frontal Cortex.

Authors:  Miquel Saumell-Esnaola; Sergio Barrondo; Gontzal García Del Caño; María Aranzazu Goicolea; Joan Sallés; Beat Lutz; Krisztina Monory
Journal:  Molecules       Date:  2021-11-16       Impact factor: 4.411

8.  SGIP1 modulates kinetics and interactions of the cannabinoid receptor 1 and G protein-coupled receptor kinase 3 signalosome.

Authors:  Matej Gazdarica; Judith Noda; Oleh Durydivka; Vendula Novosadova; Ken Mackie; Jean-Philippe Pin; Laurent Prezeau; Jaroslav Blahos
Journal:  J Neurochem       Date:  2022-01-11       Impact factor: 5.546

9.  Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB1 receptor density in cell membranes: an alternative to radioligand binding methods.

Authors:  Miquel Saumell-Esnaola; Ainhoa Elejaga-Jimeno; Leyre Echeazarra; Leire Borrega-Román; Sergio Barrondo; Maider López de Jesús; Imanol González-Burguera; Alberto Gómez-Caballero; María Aranzazu Goicolea; Joan Sallés; Gontzal García Del Caño
Journal:  Microb Cell Fact       Date:  2022-09-15       Impact factor: 6.352

10.  Ligand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1.

Authors:  Jacqueline Flores-Otero; Kwang H Ahn; Francheska Delgado-Peraza; Ken Mackie; Debra A Kendall; Guillermo A Yudowski
Journal:  Nat Commun       Date:  2014-08-01       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.